- Home
- DSL vs TNDM Comparison
DSL vs TNDM Comparison
Compare DSL & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSL
- TNDM
- Stock Information
- Founded
- DSL 2013
- TNDM 2006
- Country
- DSL United States
- TNDM United States
- Employees
- DSL N/A
- TNDM N/A
- Industry
- DSL Trusts Except Educational Religious and Charitable
- TNDM Medical/Dental Instruments
- Sector
- DSL Finance
- TNDM Health Care
- Exchange
- DSL Nasdaq
- TNDM Nasdaq
- Market Cap
- DSL 1.3B
- TNDM 1.1B
- IPO Year
- DSL N/A
- TNDM 2013
- Fundamental
- Price
- DSL $12.04
- TNDM $14.77
- Analyst Decision
- DSL
- TNDM Buy
- Analyst Count
- DSL 0
- TNDM 13
- Target Price
- DSL N/A
- TNDM $32.15
- AVG Volume (30 Days)
- DSL 393.9K
- TNDM 1.8M
- Earning Date
- DSL 01-01-0001
- TNDM 08-06-2025
- Dividend Yield
- DSL 10.97%
- TNDM N/A
- EPS Growth
- DSL N/A
- TNDM N/A
- EPS
- DSL N/A
- TNDM N/A
- Revenue
- DSL N/A
- TNDM $982,951,000.00
- Revenue This Year
- DSL N/A
- TNDM $8.91
- Revenue Next Year
- DSL N/A
- TNDM $11.04
- P/E Ratio
- DSL N/A
- TNDM N/A
- Revenue Growth
- DSL N/A
- TNDM 27.65
- 52 Week Low
- DSL $10.58
- TNDM $14.68
- 52 Week High
- DSL $13.24
- TNDM $47.60
- Technical
- Relative Strength Index (RSI)
- DSL 40.75
- TNDM 27.99
- Support Level
- DSL $12.00
- TNDM $14.87
- Resistance Level
- DSL $12.19
- TNDM $16.31
- Average True Range (ATR)
- DSL 0.07
- TNDM 0.93
- MACD
- DSL -0.02
- TNDM -0.14
- Stochastic Oscillator
- DSL 15.15
- TNDM 2.41
About DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.